VASCULAR MALFORMATIONS
Clinical trials for VASCULAR MALFORMATIONS explained in plain language.
Never miss a new study
Get alerted when new VASCULAR MALFORMATIONS trials appear
Sign up with your email to follow new studies for VASCULAR MALFORMATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to shrink overgrown tissue in rare genetic disorder
Disease control Recruiting nowThis study tests a new drug, RLY-2608, in adults and children with rare conditions that cause abnormal overgrowth of body parts (like limbs or organs) due to a PIK3CA gene mutation. The drug targets only the mutated protein to try to reduce the size of overgrown tissue and improv…
Matched conditions: VASCULAR MALFORMATIONS
Phase: PHASE2 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 06:18 UTC
-
New drug trial aims to shrink blood vessel growths without surgery
Disease control Recruiting nowThis study tests the drug everolimus in 10 adults with abnormal blood vessel growths (vascular malformations). The goal is to see if the drug can shrink these growths and lower the risk of bleeding. Participants will take the drug by mouth and have regular MRI scans to check prog…
Matched conditions: VASCULAR MALFORMATIONS
Phase: PHASE2 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for rare blood vessel disorders: targeted drugs enter trial
Disease control Recruiting nowThis study tests two targeted drugs for people with vascular malformations (abnormal blood or lymph vessels). Participants with slow-flow malformations and a specific gene mutation receive alpelisib, while those with fast-flow malformations and another mutation receive mirdametin…
Matched conditions: VASCULAR MALFORMATIONS
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated May 19, 2026 12:00 UTC